Current therapies for paraneoplastic neurologic syndromes

被引:15
作者
Myrna R. Rosenfeld
Josep Dalmau
机构
[1] Hospital of the University of Pennsylvania,Department of Neurology
关键词
Main Drug Interaction; Limbic Encephalitis; Paraneoplastic Neurologic Syndrome; Lambert Eaton Myasthenic Syndrome; Paraneoplastic Cerebellar Degeneration;
D O I
10.1007/s11940-003-0023-y
中图分类号
学科分类号
摘要
Paraneoplastic neurologic syndromes (PNS) comprise an extensive group of heterogeneous disorders that can affect any part of the central and peripheral nervous system. There is evidence that many of these disorders are mediated by immunologic responses triggered by the presence of a cancer. Several immunologic mechanisms and many antigenic targets have been related to these disorders. Some disorders of the neuromuscular junction or peripheral nervous system are directly mediated by antibodies, and they may have a paraneoplastic origin or develop without a tumor association. For these disorders and a few PNS of the central nervous system, immunotherapy may result in neurologic improvement. However, for most PNS of the peripheral and central nervous system the response to any type of therapy is, in general, disappointing. The main concern of the clinician should be to rule out other diagnostic entities and to uncover the presence of the associated neoplasm that often remains elusive to detection. In general, the best approach to treat PNS is to discover and treat the tumor promptly, and provide supportive care for the neurologic deficits with symptomatic treatment and physical therapy. In a few cases, depending on the syndrome and if the patient is in the early stages of the neurologic disease, treatment with immunosuppression may have some effect on the PNS.
引用
收藏
页码:69 / 77
页数:8
相关论文
共 50 条
[21]   Paraneoplastic syndromes in neuro-ophthalmology [J].
Alabduljalil, Talal ;
Behbehani, Raed .
CURRENT OPINION IN OPHTHALMOLOGY, 2007, 18 (06) :463-469
[22]   Paraneoplastic neurological syndromes: diagnosis and treatment [J].
Graus, Francesc ;
Dalmau, Josep .
CURRENT OPINION IN NEUROLOGY, 2007, 20 (06) :732-737
[23]   Autoimmune channelopathies in paraneoplastic neurological syndromes [J].
Joubert, Bastien ;
Honnorat, Jerome .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2015, 1848 (10) :2665-2676
[24]   Paraneoplastic Neurologic Disorders in Children [J].
Wells, Elizabeth M. ;
Dalmau, Josep .
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2011, 11 (02) :187-194
[25]   Treatment of Paraneoplastic Neurologic Disorders [J].
Greenlee, John E. .
CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2010, 12 (03) :212-230
[26]   Paraneoplastic Neurologic Disorders in Children [J].
Elizabeth M. Wells ;
Josep Dalmau .
Current Neurology and Neuroscience Reports, 2011, 11 :187-194
[27]   Paraneoplastic neurological syndromes [J].
Leypoldt, F. ;
Wandinger, K. -P. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2014, 175 (03) :336-348
[28]   Paraneoplastic neurological syndromes [J].
Jérôme Honnorat ;
Jean-Christophe Antoine .
Orphanet Journal of Rare Diseases, 2
[29]   Paraneoplastic neurological syndromes [J].
Didelot, A. ;
Honnorat, J. .
REVUE DE MEDECINE INTERNE, 2011, 32 (10) :605-611
[30]   Paraneoplastic neurological syndromes [J].
Iorio, Raffaele ;
Spagni, Gregorio ;
Masi, Gianvito .
SEMINARS IN DIAGNOSTIC PATHOLOGY, 2019, 36 (04) :279-292